| Cipla Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500087 |
NSE Symbol : CIPLA |
P/E(TTM) : 23.42 |
|
ISIN Demat : INE059A01026 |
Div & Yield% : 1.06 |
EPS(TTM) : 64.35 |
|
Book Value(₹) : 411.56 |
Market Cap(₹Cr) : 121,751.32 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 19,044.85 | 16,574.34 | 14,345.34 | 13,091.79 | 11,302.71 |
| Other Income | 1,279.38 | 1,433.72 | 826.20 | 935.24 | 653.91 |
| Stock Adjustments | 229.87 | -104.57 | -194.32 | 528.40 | -6.41 |
| Total Income | 20,554.10 | 17,903.49 | 14,977.22 | 14,555.43 | 11,950.21 |
| EXPENDITURE : | |||||
| Raw Materials | 5,699.59 | 4,977.62 | 4,739.89 | 5,618.64 | 4,097.20 |
| Power and Fuel Cost | 290.24 | 271.66 | 257.07 | 247.58 | 234.58 |
| Other Manufacturing Expenses | 1,374.94 | 1,243.47 | 988.99 | 994.55 | 906.09 |
| Selling and Administration Expenses | 2,604.73 | 2,510.53 | 2,334.97 | 2,107.17 | 1,578.59 |
| Miscellaneous Expenses | 471.91 | 293.83 | 282.43 | -443.38 | -291.15 |
| Employee Benefit Expenses | 3,054.87 | 2,688.51 | 2,380.68 | 1,729.16 | 1,703.58 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 7,057.82 | 5,917.87 | 3,993.19 | 4,301.71 | 3,721.32 |
| Interest | 15.11 | 20.25 | 22.27 | 26.93 | 45.07 |
| Gross Profit | 7,042.71 | 5,897.62 | 3,970.92 | 4,274.78 | 3,676.25 |
| Depreciation | 573.89 | 587.59 | 595.91 | 460.01 | 468.62 |
| Profit Before Tax | 6,468.82 | 5,310.03 | 3,375.01 | 3,814.77 | 3,207.63 |
| Current Tax | 1,360.32 | 1,226.69 | 901.63 | 887.24 | 756.27 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -49.15 | 6.09 | -40.09 | -30.40 | -16.92 |
| Reported Net Profit | 5,157.65 | 4,077.25 | 2,513.47 | 2,957.93 | 2,468.28 |
| Extraordinary Items | 344.27 | 39.14 | -41.59 | 49.67 | 39.09 |
| Adjusted Net Profit | 4,813.38 | 4,038.11 | 2,555.06 | 2,908.26 | 2,429.19 |
| Adjustment below Net Profit | -12.96 | -74.47 | -10.52 | 18.48 | 13.71 |
| Profit/Loss Balance carried down | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 | 12,479.72 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,049.83 | 686.17 | 403.50 | 403.35 | 0.00 |
| P & L Balance carried down | 27,045.69 | 22,950.83 | 19,634.22 | 17,534.77 | 14,961.71 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 800.00 | 650.00 | 425.00 | 250.00 | 250.00 |
| Dividend Per Share(Rs) | 16.00 | 13.00 | 8.50 | 5.00 | 5.00 |
| Earnings Per Share-Unit Curr | 63.86 | 50.50 | 31.14 | 36.66 | 30.61 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 397.46 | 346.49 | 305.25 | 279.05 | 247.10 |
| Book Value(Adj)-Unit Curr | 397.46 | 346.49 | 305.25 | 279.05 | 247.10 |